Main > ONCOLOGY (**) > Prostate Cancer MET *** > Treatment > TW. F. GnRH Receptor Antagonist

---

TW. F. GnRH Receptor Antagonist's subsections
(*) USA Approval Date: 2021. 05.26
Company
Company DIST. USA
Generic Name: leuprolide mesylate
GnRH: Gonadotropin Releasing Hormon
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 05.25.
RTM

TW. F. GnRH Receptor Antagonist's products
This section has no products